Convection-enhanced delivery of carboplatin PLGA nanoparticles for the treatment of glioblastoma

Azeem Arshad, Bin Yang, Alison S. Bienemann, Neil U. Barua, Marcella J. Wyatt, Max Woolley, Dave E. Johnson, Karen J. Edler, Steven S. Gill

Research output: Contribution to journalArticlepeer-review

71 Citations (SciVal)


We currently use Convection-Enhanced Delivery (CED) of the platinum-based drug, carboplatin as a novel treatment strategy for high grade glioblastoma in adults and children. Although initial results show promise, carboplatin is not specifically toxic to tumour cells and has been associated with neurotoxicity at high infused concentrations in pre-clinical studies. Our treatment strategy requires intermittent infusions due to rapid clearance of carboplatin from the brain. In this study, carboplatin was encapsulated in lactic acid-glycolic acid copolymer (PLGA) to develop a novel drug delivery system. Neuronal and tumour cytotoxicity were assessed in primary neuronal and glioblastoma cell cultures. Distribution, tissue clearance and toxicity of carboplatin nanoparticles following CED was assessed in rat and porcine models. Carboplatin nanoparticles conferred greater tumour cytotoxicity, reduced neuronal toxicity and prolonged tissue half-life. In conclusion, this drug delivery system has the potential to improve the prognosis for patients with glioblastomas.

Original languageEnglish
Article numbere0132266
JournalPLoS ONE
Issue number7
Publication statusPublished - 17 Jul 2015

Bibliographical note

open access


Dive into the research topics of 'Convection-enhanced delivery of carboplatin PLGA nanoparticles for the treatment of glioblastoma'. Together they form a unique fingerprint.

Cite this